Literature DB >> 7504504

The role of cytokines in the generation of skin lesions in dermatitis herpetiformis.

M Graeber1, B S Baker, J J Garioch, H Valdimarsson, J N Leonard, L Fry.   

Abstract

The infiltration of polymorphonuclear neutrophils (PMN) into the upper dermis which characterizes the skin lesions of dermatitis herpetiformis (DH) has never been satisfactorily explained. This study has shown that lesional skin of patients with DH has increased expression of endothelial leucocyte adhesion molecules (ELAM) in the deep dermis, combined with a markedly increased staining for interleukin 8 (IL-8) in the basal epidermal layer. Dendritic cells which stained for granulocyte macrophage colony stimulating factor (GM-CSF) were also observed at the dermo-epidermal junction, and this phenomenon was more pronounced in lesional than in uninvolved DH skin. ELAM, IL-8 and GM-CSF are known to promote infiltration and activation of PMN, and it is suggested that these cytokines may play a key role in the generation of DH lesions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504504     DOI: 10.1111/j.1365-2133.1993.tb00479.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

2.  Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

Authors:  P Desreumaux; A Janin; E Delaporte; S Dubucquoi; F Piette; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

3.  The role of cytokines in the pathomechanism of cutaneous disorders.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

4.  The expression of selected proapoptotic molecules in dermatitis herpetiformis.

Authors:  Zebrowska Agnieszka; Erkiert-Polguj Anna; Wagrowska-Danilewicz Malgorzata; Danilewicz Marian; Sysa-Jedrzejowska Anna; Anna Cynkier; Waszczykowska Elzbieta
Journal:  Clin Dev Immunol       Date:  2012-06-20

5.  Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wagrowska-Danilewicz; J Wieczfinska; R Pawliczak; A Zebrowska
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

6.  The Role of Intereukin-31 in Pathogenesis of Itch and Its Intensity in a Course of Bullous Pemphigoid and Dermatitis Herpetiformis.

Authors:  Lilianna Kulczycka-Siennicka; Anna Cynkier; Elżbieta Waszczykowska; Anna Woźniacka; Agnieszka Żebrowska
Journal:  Biomed Res Int       Date:  2017-07-20       Impact factor: 3.411

Review 7.  Dermatitis Herpetiformis: Novel Perspectives.

Authors:  Emiliano Antiga; Roberto Maglie; Lavinia Quintarelli; Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

Review 8.  Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.

Authors:  Esko Kemppainen; Teea Salmi; Katri Lindfors
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

9.  Expression of selected integrins and selectins in bullous pemphigoid.

Authors:  Agnieszka Zebrowska; Anna Sysa-Jedrzejowska; Małgorzata Wagrowska-Danilewicz; Ewa Joss-Wichman; Anna Erkiert-Polguj; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2007-04-02       Impact factor: 4.711

10.  The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.

Authors:  Agnieszka Zebrowska; Joanna Narbutt; Anna Sysa-Jedrzejowska; Jozef Kobos; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.